We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 356 results
  1. Heterologous Expression of Candida Antifungal Target Genes in the Model Organism Saccharomyces cerevisiae

    Understanding how a gene variant may influence antifungal resistance, or other phenotypic characteristics, is an important step in determining or...
    Kelley R. Healey, Ashutosh Singh in Antifungal Drug Resistance
    Protocol 2023
  2. Chemical-Genetic Approaches for Exploring Mode of Action of Antifungal Compounds in the Fungal Pathogen Candida albicans

    Candida albicans is a prevalent fungal pathogen of humans that can cause both superficial and life-threatening disease, primarily in...
    Nicole Robbins, Troy Ketela, ... Leah E. Cowen in Antifungal Drug Resistance
    Protocol 2023
  3. Characterizing Candida glabrata Pdr1, a Hyperactive Transcription Factor Involved in Azole Resistance

    This chapter illustrates how to prepare isogenic strains carrying gain-of-function forms of transcription factor Pdr1 in the human pathogen Candida...
    Lucia Simonicova, W. Scott Moye-Rowley in Antifungal Drug Resistance
    Protocol 2023
  4. Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformans

    Drug target identification is an essential component to antifungal drug development. Many methods, including large chemical library screening,...
    Michael J. Hoy, Joseph Heitman in Antifungal Drug Resistance
    Protocol 2023
  5. Genome-Wide Identification of Variants Associated with Antifungal Drug Resistance

    Genomic approaches are widely applied to study the genetic basis of antifungal drug resistance in clinical isolates and experimental studies....
    Aina Martinez-Zurita, Christina A. Cuomo in Antifungal Drug Resistance
    Protocol 2023
  6. Conditional Protein Depletion in the Analysis of Antifungal Drug Resistance in Candida glabrata

    This chapter illustrates a method to generate Candida glabrata conditional depletion mutants for SNF2, an ATPase subunit of the SWI/SNF chromatin...
    Thomas P. Conway, W. Scott Moye-Rowley in Antifungal Drug Resistance
    Protocol 2023
  7. Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice

    The human fungal pathogen Candida glabrata is less virulent compared to the most isolated Candida species including Candida albicans. Its reduced...
    Sanne Schrevens, Riccardo Torelli, ... Dominque Sanglard in Antifungal Drug Resistance
    Protocol 2023
  8. Analysis of Candida Antifungal Resistance Using Animal Infection Models

    Candida frequently produces three general disease states, including mucosal candidiasis, disseminated candidiasis, and biofilm infection (which can...
    David R. Andes, Jeniel E. Nett in Antifungal Drug Resistance
    Protocol 2023
  9. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening

    Candidiasis, infections caused by Candida spp., represents one of the most common nosocomial infections afflicting an expanding number of compromised...
    Olabayo H. Ajetunmobi, Gina Wall, ... Jose L. Lopez-Ribot in Antifungal Drug Resistance
    Protocol 2023
  10. Transport Across Membranes: Techniques for Measuring Drug Import in Fungal Cells

    The ability of many antifungal molecules to traverse the fungal cell wall and accumulate within the cell is crucial to its ability to have the...
    Brooke D. Esquivel, Theodore C. White in Antifungal Drug Resistance
    Protocol 2023
  11. Antifungal Susceptibility Testing and Drug Discovery in the Dimorphic Fungus Histoplasma Capsulatum

    The thermal dimorphism of the fungal pathogen Histoplasma is linked to its virulence in mammalian hosts. Mammalian body temperature triggers...
    Chad A. Rappleye in Antifungal Drug Resistance
    Protocol 2023
  12. Transport across Membranes: Techniques for Measuring Efflux in Fungal Cells

    One of the most prevalent mechanisms of antifungal drug resistance is export of the molecule from the fungal cells through the action of putative...
    Brooke D. Esquivel, Theodore C. White in Antifungal Drug Resistance
    Protocol 2023
  13. Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small Molecules

    Only three classes of contemporary antifungal drugs are routinely utilized in the clinic against filamentous fungal pathogens such as Aspergillus...
    Timothy J. Opperman, Sourabh Dhingra, ... Robert A. Cramer in Antifungal Drug Resistance
    Protocol 2023
  14. Copy Number Variation and Allele Ratio Analysis in Candida albicans Using Whole Genome Sequencing Data

    Whole genome sequencing of human fungal pathogens has revolutionized the speed and accuracy in which sequence variants that cause antifungal...
    Robert T. Todd, Anna Selmecki in Antifungal Drug Resistance
    Protocol 2023
  15. A Dual-Readout High-Throughput Screening Assay for Small Molecules Active Against Aspergillus Fumigatus

    Human fungal infections caused by molds have been on the rise in recent years. These infections have high mortality rates compared to other fungal...
    Sarah R. Beattie, Damian J. Krysan in Antifungal Drug Resistance
    Protocol 2023
  16. Protocols for Measuring Tolerant and Heteroresistant Drug Responses of Pathogenic Yeasts

    The classic definition of antimicrobial susceptibility to antifungal drugs ignores the persistence of subpopulations that survive in the presence of...
    Naomi Lyons, Judith Berman in Antifungal Drug Resistance
    Protocol 2023
  17. Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing

    Antifungal susceptibility testing is performed against yeasts and filamentous fungi (molds) for various purposes. In clinical settings, the results...
    Nathan P. Wiederhold in Antifungal Drug Resistance
    Protocol 2023
  18. Zika Virus Isolation, Purification, and Titration

    Zika virus (ZIKV) is an important pathogen transmitted to humans by the mosquito vector Aedes aegypti. ZIKV is able to infect several tissues and...
    Mariana Baz in Zika Virus
    Protocol 2020
  19. Use of Primary Human Fetal Astrocytes and Tissue Explants as Ex Vivo Models to Study Zika Virus Infection of the Develo** Brain

    Zika virus (ZIKV) infection during pregnancy can result in congenital Zika syndrome which is characterized by microcephaly and other...
    Daniel Limonta, William Branton, ... Tom C. Hobman in Zika Virus
    Protocol 2020
  20. Liver Fluke Vaccine Assessment in Cattle

    Liver fluke Fasciola hepatica remains an important agent of foodborne trematode disease producing great economic losses due to its negative effect on...
    Gabriela Maggioli, Cecilia Salazar, ... Carlos Carmona in Fasciola hepatica
    Protocol 2020
Did you find what you were looking for? Share feedback.